SCHEMBL29601635

SCHEMBL29601635

CCCc1nn(C)c2c(=O)[nH]c(-c3cc(S(=O)(=O)NC4CN(CCCO)C4)ccc3OCC)nc12

nearest known ligand 0.76

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PDE5A O76074 17/20 0.76
▸ PDE2A O00408 2/20 0.74
▸ PDE9A O76083 2/20 0.74
▸ PDE4A P27815 2/20 0.74
▸ PDE6C P51160 2/20 0.74
▸ PDE1A P54750 2/20 0.74
▸ PDE11A Q9HCR9 2/20 0.74
▸ PDE10A Q9Y233 2/20 0.74
▸ KDM4E B2RXH2 1/20 0.72
▸ PDE3B Q13370 2/20 0.68
▸ PDE3A Q14432 2/20 0.68
▸ POLB P06746 1/20 0.67
▸ KMT2A Q03164 1/20 0.67
▸ HDAC3 O15379 1/20 0.67
▸ HDAC1 Q13547 1/20 0.67
▸ HDAC2 Q92769 1/20 0.67
▸ HDAC6 Q9UBN7 1/20 0.67
▸ NCOR2 Q9Y618 1/20 0.67
▸ ABCC4 O15439 1/20 0.64
▸ ABCC5 O15440 1/20 0.64

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23361310 1.00 PDE5A (0.76) PDE5APDE2APDE9APDE4APDE6C
SCHEMBL23370692 0.98 PDE5A (0.77) PDE5APDE2APDE9APDE4APDE6C
SCHEMBL23361343 0.96 PDE5A (0.74) PDE5APDE2APDE9APDE4APDE6C
SCHEMBL29602240 0.96 PDE5A (0.74) PDE5APDE2APDE9APDE4APDE6C
SCHEMBL23361697 0.90 PDE5A (0.65) PDE5APDE2APDE9APDE4APDE6C
SCHEMBL23370767 0.90 KDM4E (0.67) PDE5APDE2APDE9APDE4APDE6C
SCHEMBL28890828 0.89 KDM4E (0.73) PDE5APDE2APDE9APDE4APDE6C
SCHEMBL29601997 0.88 KDM4E (0.78) PDE5APDE2APDE9APDE4APDE6C
SCHEMBL23362150 0.88 KDM4E (0.78) PDE5APDE2APDE9APDE4APDE6C
SCHEMBL23370716 0.88 KDM4E (0.69) PDE5APDE2APDE9APDE4APDE6C

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4058457-A2 NITROGEN OXIDE-DONATING PDE-5 AND/OR PDE-6 INHIBITOR COMPOUNDS Ildong Pharmaceutical Co., Ltd. (KR) 2022-09-21 — — EP disclosed
US-20220153746-A1 NITROGEN OXIDE-DONATING PDE-5 AND/OR PDE-6 INHIBITOR COMPOUNDS, AND USES THEREOF ILDONG PHARMACEUTICAL CO., LTD. (KR) 2022-05-19 — — US disclosed
WO-2022096930-A2 NITROGEN OXIDE-DONATING PDE-5 AND/OR PDE-6 INHIBITOR COMPOUNDS, AND USES THEREOF ILDONG PHARMACEUTICAL CO., LTD. (KR) 2022-05-12 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220153746-A1 NITROGEN OXIDE-DONATING PDE-5 AND/OR PDE-6 INHIBITOR COMPOUNDS, AND USES THEREOF PDE6G, PRKG1, PDE6D PDE5A 4/4885PDE2A 8/4885PDE9A 14/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback